Biotech | April 16, 2026
Clean Cells, Naobios step up Asia expansion at BIO KOREA 2026 in Seoul
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The presentations underscore the company’s deep expertise in dermatology and immunology
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
The protections extend through at least 2035, with the potential for further extensions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
